Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Vertex Pharmaceuticals Stock Quote

Vertex Pharmaceuticals (NASDAQ: VRTX)

Price as of September 25, 2023, 10:20 a.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Vertex Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
VRTX +22.07% +94.10% +14.17% +7,457%
S&P +14.96% +47.46% +8.07% +1,041%

Vertex Pharmaceuticals Company Info

Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.

News & Analysis

The Fool has written over 900 articles on Vertex Pharmaceuticals.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.